Patent: 10,119,976
✉ Email this page to a colleague
Summary for Patent: 10,119,976
Title: | Method of assessing risk of PML |
Abstract: | The invention relates to methods of assessing a patient\'s risk of developing Progressive multifocal leukoencephalopathy (PML). |
Inventor(s): | Bloomgren; Gary Lewis (Concord, MA), Bozic; Carmen (Newton, MA), Lee; Sophia (Waltham, MA), Pace; Amy (Brookline, MA), Plavina; Tatiana (North Reading, MA), Subramanyam; Meena (Stoneham, MA) |
Assignee: | Biogen MA Inc. (Cambridge, MA) |
Application Number: | 14/893,989 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,119,976 |
Patent Claims: | see list of patent claims |
Details for Patent 10,119,976
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Biogen Inc. | TYSABRI | natalizumab | Injection | 125104 | 11/23/2004 | ⤷ Try a Trial | 2033-05-28 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |